These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29076965)

  • 61. AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature.
    Pettersen HS; Galashevskaya A; Doseth B; Sousa MM; Sarno A; Visnes T; Aas PA; Liabakk NB; Slupphaug G; Sætrom P; Kavli B; Krokan HE
    DNA Repair (Amst); 2015 Jan; 25():60-71. PubMed ID: 25486549
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Key Genetic and Epigenetic Mechanisms in Chemical Carcinogenesis.
    Ravegnini G; Sammarini G; Hrelia P; Angelini S
    Toxicol Sci; 2015 Nov; 148(1):2-13. PubMed ID: 26500287
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cancer genetics.
    Ponder BA
    Nature; 2001 May; 411(6835):336-41. PubMed ID: 11357140
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Challenge assay: A functional biomarker for exposure-induced DNA repair deficiency and for risk of cancer.
    Au WW; Giri AK; Ruchirawat M
    Int J Hyg Environ Health; 2010 Jan; 213(1):32-9. PubMed ID: 19818682
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Somatic hypermutation in immunity and cancer: Critical analysis of strand-biased and codon-context mutation signatures.
    Steele EJ
    DNA Repair (Amst); 2016 Sep; 45():1-24. PubMed ID: 27449479
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genome-Wide Locations of Potential Epimutations Associated with Environmentally Induced Epigenetic Transgenerational Inheritance of Disease Using a Sequential Machine Learning Prediction Approach.
    Haque MM; Holder LB; Skinner MK
    PLoS One; 2015; 10(11):e0142274. PubMed ID: 26571271
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cancer control and prevention: nutrition and epigenetics.
    Verma M
    Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):376-84. PubMed ID: 23676683
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chemical and physical carcinogenesis: advances and perspectives for the 1990s.
    Harris CC
    Cancer Res; 1991 Sep; 51(18 Suppl):5023s-5044s. PubMed ID: 1884379
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detecting presence of mutational signatures in cancer with confidence.
    Huang X; Wojtowicz D; Przytycka TM
    Bioinformatics; 2018 Jan; 34(2):330-337. PubMed ID: 29028923
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mutational interactions define novel cancer subgroups.
    Kuipers J; Thurnherr T; Moffa G; Suter P; Behr J; Goosen R; Christofori G; Beerenwinkel N
    Nat Commun; 2018 Oct; 9(1):4353. PubMed ID: 30341300
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers.
    Lim AH; Chan JY; Yu MC; Wu TH; Hong JH; Ng CCY; Low ZJ; Liu W; Vikneswari R; Sung PC; Fan WL; Teh BT; Hsieh SY
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158844
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mutational signature learning with supervised negative binomial non-negative matrix factorization.
    Lyu X; Garret J; Rätsch G; Lehmann KV
    Bioinformatics; 2020 Jul; 36(Suppl_1):i154-i160. PubMed ID: 32657388
    [TBL] [Abstract][Full Text] [Related]  

  • 73. From Mutational Mechanisms in Single Cells to Mutational Patterns in Cancer Genomes.
    Zhang CZ; Pellman D
    Cold Spring Harb Symp Quant Biol; 2015; 80():117-37. PubMed ID: 26968629
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genotype, phenotype and cancer: role of low penetrance genes and environment in tumour susceptibility.
    Kotnis A; Sarin R; Mulherkar R
    J Biosci; 2005 Feb; 30(1):93-102. PubMed ID: 15824445
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pan-cancer mutational signature surveys correlated mutational signature with geospatial environmental exposures and viral infections.
    Bai J; Ma K; Xia S; Geng R; Shen C; Jiang L; Gong X; Yu H; Leng S; Guo Y
    Comput Struct Biotechnol J; 2023; 21():5413-5422. PubMed ID: 38022689
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Huge Genome Study Uncovers Mutational Signatures.
    Cancer Discov; 2022 Jul; 12(7):OF1. PubMed ID: 35612276
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Developing the environmental and lifestyle exposure assessment (ELEA) tool for cancer epidemiology research in low resource settings.
    Feletto E; Schüz J; Sitas F
    J Glob Health; 2016 Dec; 6(2):020307. PubMed ID: 27606057
    [No Abstract]   [Full Text] [Related]  

  • 78. Resolving mutational signatures in cancer development.
    Liu T; Lin Y; Wu C
    Cancer Cell; 2022 Jul; 40(7):711-713. PubMed ID: 35688149
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A mutation-level covariate model for mutational signatures.
    Kahane I; Leiserson MDM; Sharan R
    PLoS Comput Biol; 2023 Jun; 19(6):e1011195. PubMed ID: 37276234
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intrinsic versus Extrinsic Cancer Risks: The Debate Continues.
    Thomas F; Roche B; Ujvari B
    Trends Cancer; 2016 Feb; 2(2):68-69. PubMed ID: 28741552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.